SG11201406945QA - Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds - Google Patents
Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compoundsInfo
- Publication number
- SG11201406945QA SG11201406945QA SG11201406945QA SG11201406945QA SG11201406945QA SG 11201406945Q A SG11201406945Q A SG 11201406945QA SG 11201406945Q A SG11201406945Q A SG 11201406945QA SG 11201406945Q A SG11201406945Q A SG 11201406945QA SG 11201406945Q A SG11201406945Q A SG 11201406945QA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- deoxy
- fluoro
- south carolina
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12169760 | 2012-05-29 | ||
| PCT/EP2013/060836 WO2013178571A1 (en) | 2012-05-29 | 2013-05-27 | Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201406945QA true SG11201406945QA (en) | 2014-12-30 |
Family
ID=48520966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406945QA SG11201406945QA (en) | 2012-05-29 | 2013-05-27 | Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20130324709A1 (pt) |
| EP (1) | EP2855497B1 (pt) |
| JP (1) | JP2015518017A (pt) |
| KR (1) | KR20150018524A (pt) |
| CN (1) | CN104379591A (pt) |
| AR (1) | AR091166A1 (pt) |
| AU (1) | AU2013269799A1 (pt) |
| BR (1) | BR112014028692A2 (pt) |
| CA (1) | CA2872171A1 (pt) |
| ES (1) | ES2583375T3 (pt) |
| HK (1) | HK1207384A1 (pt) |
| IL (1) | IL234673A0 (pt) |
| MX (1) | MX2014014087A (pt) |
| NZ (1) | NZ631182A (pt) |
| PT (1) | PT2855497T (pt) |
| RU (1) | RU2014149148A (pt) |
| SG (1) | SG11201406945QA (pt) |
| WO (1) | WO2013178571A1 (pt) |
| ZA (1) | ZA201407529B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD761840S1 (en) | 2011-06-28 | 2016-07-19 | Google Inc. | Display screen or portion thereof with an animated graphical user interface of a programmed computer system |
| CN104817599B (zh) * | 2015-03-20 | 2018-02-27 | 南京欧信医药技术有限公司 | 一种5‑羟基四氢呋喃衍生物的合成方法 |
| CN105017183B (zh) * | 2015-07-16 | 2018-06-12 | 江苏福瑞生物医药有限公司 | 一种药物中间体的结晶方法 |
| CN105061535A (zh) * | 2015-09-02 | 2015-11-18 | 江苏科本医药化学有限公司 | 一种索非布韦中间体的合成方法 |
| CN107805266A (zh) * | 2016-09-09 | 2018-03-16 | 上海度德医药科技有限公司 | 作为索非布韦中间体的2‑氟‑2‑甲基脱氧核苷的制备方法 |
| CN107629099B (zh) * | 2017-07-26 | 2020-05-26 | 江苏科本药业有限公司 | 一种索非布韦中间体的制备工艺 |
| CN109422781B (zh) * | 2017-08-25 | 2022-01-18 | 江苏瑞科医药科技有限公司 | 一种(2r)-2-脱氧-2-氟-2-甲基-d-呋喃核糖基氯化物的制备方法 |
| CN109422789A (zh) * | 2017-08-28 | 2019-03-05 | 常州制药厂有限公司 | 一种索非布韦的制备工艺改进方法 |
| CN109438537A (zh) * | 2018-11-20 | 2019-03-08 | 江苏科本药业有限公司 | 一种索非布韦关键中间体的制备方法 |
| CN111269282A (zh) * | 2020-03-20 | 2020-06-12 | 江苏阿尔法药业有限公司 | 连续流微通道反应器制备索非布韦中间体的方法 |
| WO2024030429A1 (en) * | 2022-08-01 | 2024-02-08 | The United States Government, As Represented By The Secretary Of The Army | Base-modified ribonucleosides as prodrugs against viral and bacterial infections |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006031725A2 (en) * | 2004-09-14 | 2006-03-23 | Pharmasset, Inc. | Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| EP1957510A1 (en) | 2005-12-09 | 2008-08-20 | F.Hoffmann-La Roche Ag | Antiviral nucleosides |
| CA2666098C (en) | 2006-10-10 | 2012-09-25 | Steven D. Axt | Preparation of nucleosides ribofuranosyl pyrimidines |
| CN101024667B (zh) * | 2007-03-30 | 2011-01-26 | 湖北益泰药业有限公司 | 盐酸吉西他宾的合成方法 |
| EP2048151A1 (en) * | 2007-10-10 | 2009-04-15 | Cilag AG | Method for producing nucleosides by direct glycosylation of the nucleoside base |
| US8173621B2 (en) * | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
| NZ593648A (en) * | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
-
2013
- 2013-05-27 KR KR1020147033378A patent/KR20150018524A/ko not_active Application Discontinuation
- 2013-05-27 CA CA2872171A patent/CA2872171A1/en not_active Abandoned
- 2013-05-27 ES ES13725159.1T patent/ES2583375T3/es active Active
- 2013-05-27 MX MX2014014087A patent/MX2014014087A/es unknown
- 2013-05-27 WO PCT/EP2013/060836 patent/WO2013178571A1/en active Application Filing
- 2013-05-27 NZ NZ631182A patent/NZ631182A/en not_active IP Right Cessation
- 2013-05-27 CN CN201380027875.4A patent/CN104379591A/zh active Pending
- 2013-05-27 EP EP13725159.1A patent/EP2855497B1/en not_active Not-in-force
- 2013-05-27 SG SG11201406945QA patent/SG11201406945QA/en unknown
- 2013-05-27 BR BR112014028692A patent/BR112014028692A2/pt not_active Application Discontinuation
- 2013-05-27 RU RU2014149148A patent/RU2014149148A/ru unknown
- 2013-05-27 AR ARP130101838 patent/AR091166A1/es unknown
- 2013-05-27 PT PT137251591T patent/PT2855497T/pt unknown
- 2013-05-27 AU AU2013269799A patent/AU2013269799A1/en not_active Abandoned
- 2013-05-27 JP JP2015514444A patent/JP2015518017A/ja active Pending
- 2013-05-28 US US13/903,726 patent/US20130324709A1/en not_active Abandoned
-
2014
- 2014-09-16 IL IL234673A patent/IL234673A0/en unknown
- 2014-10-16 ZA ZA2014/07529A patent/ZA201407529B/en unknown
-
2015
- 2015-08-21 HK HK15108122.7A patent/HK1207384A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20130324709A1 (en) | 2013-12-05 |
| JP2015518017A (ja) | 2015-06-25 |
| KR20150018524A (ko) | 2015-02-23 |
| ES2583375T3 (es) | 2016-09-20 |
| RU2014149148A (ru) | 2016-07-20 |
| IL234673A0 (en) | 2014-11-30 |
| AU2013269799A1 (en) | 2014-10-02 |
| CN104379591A (zh) | 2015-02-25 |
| EP2855497A1 (en) | 2015-04-08 |
| MX2014014087A (es) | 2015-01-26 |
| PT2855497T (pt) | 2016-07-28 |
| ZA201407529B (en) | 2015-12-23 |
| AR091166A1 (es) | 2015-01-14 |
| WO2013178571A1 (en) | 2013-12-05 |
| BR112014028692A2 (pt) | 2017-06-27 |
| CA2872171A1 (en) | 2013-12-05 |
| EP2855497B1 (en) | 2016-04-20 |
| NZ631182A (en) | 2015-09-25 |
| HK1207384A1 (en) | 2016-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201406945QA (en) | Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds | |
| SG11201804398XA (en) | Method for producing rna molecule compositions | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201806863WA (en) | Tetracyclic pyridone compounds as antivirals | |
| SG11201406888QA (en) | Lysin-glutamic acid dipeptide derivatives | |
| SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
| SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| SG11201909432SA (en) | Compounds for increasing genome editing efficiency | |
| SG11201408539UA (en) | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | |
| SG11201408094YA (en) | Neprilysin inhibitors | |
| SG11201407533SA (en) | Antiviral compounds | |
| SG11201901633WA (en) | 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection | |
| SG11201803627XA (en) | N-substituted indole derivatives as pge2 receptor modulators | |
| SG11201408791TA (en) | Dihydropyrimidine compounds and their application in pharmaceuticals | |
| SG11201805595TA (en) | Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid | |
| SG11201408261UA (en) | Syringe | |
| SG11201900633XA (en) | Piperidine cxcr7 receptor modulators | |
| SG11201407546QA (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
| SG11201810429UA (en) | Anti-cd19 antibody formulations | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201805191SA (en) | Yeast cell | |
| SG11201407575PA (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
| SG11201408785VA (en) | Chemical mechanical polishing composition comprising non-ionic surfactant and aromatic compound comprising at least one acid group | |
| SG11201803979PA (en) | Sulfur-containing compounds as solvents |